Concord Wealth Partners’s Halozyme HALO Stock Holding History

Concord Wealth Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.17K	Buy	+66	New	+$4.5K	﹤0.01%	656
2026 Q1	–	Sell	-66	Closed	-$4.44K	–	442
2025 Q4	$4.44K	Hold	66	–	–	﹤0.01%	639
2025 Q3	$4.84K	Hold	66	–	–	﹤0.01%	628
2025 Q2	$3.43K	Hold	66	–	–	﹤0.01%	677
2025 Q1	$4.21K	Hold	66	–	–	﹤0.01%	606
2024 Q4	$3.15K	Hold	66	–	–	﹤0.01%	658
2024 Q3	$3.78K	Hold	66	–	–	﹤0.01%	674
2024 Q2	$3.46K	Hold	66	–	–	﹤0.01%	617
2024 Q1	$2.69K	Hold	66	–	–	﹤0.01%	721
2023 Q4	$2.44K	Hold	66	–	–	﹤0.01%	695
2023 Q3	$2.52K	Hold	66	–	–	﹤0.01%	837
2023 Q2	$2.38K	Hold	66	–	–	﹤0.01%	837
2023 Q1	$2.52K	Hold	66	–	–	﹤0.01%	778
2022 Q4	$3.75K	Buy	+66	New	+$3.38K	﹤0.01%	821
2022 Q3	–	Sell	-66	Closed	-$3K	–	559
2022 Q2	$3K	Hold	66	–	–	﹤0.01%	942
2022 Q1	$3K	Hold	66	–	–	﹤0.01%	1016
2021 Q4	$3K	Hold	66	–	–	﹤0.01%	1055
2021 Q3	$3K	Hold	66	–	–	﹤0.01%	686
2021 Q2	$3K	Hold	66	–	–	﹤0.01%	816
2021 Q1	$3K	Hold	66	–	–	﹤0.01%	756
2020 Q4	$3K	Buy	+66	New	+$2.37K	﹤0.01%	470

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Concord Wealth Partners's HALO Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Halozyme (HALO) in Q2 2026: 66 shares worth $5.17K. The stake represents ﹤0.01% of the portfolio and ranks #656 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in HALO as recently as Q4 2025.

Concord Wealth Partners first reported a position in HALO in Q4 2020 and has held it in 21 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Concord Wealth Partners held 66 shares of Halozyme worth $5.17K as of Q2 2026.
Halozyme was a new Concord Wealth Partners position in Q2 2026.
Halozyme made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #656 holding.
Concord Wealth Partners first reported a position in Halozyme in Q4 2020 and has held it in 21 quarters since.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.